Saved in:
| Main Author: | |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Universidad del Valle
2022
|
| Subjects: | |
| Online Access: | https://www.redalyc.org/articulo.oa?id=28371551002 https://www.redalyc.org/journal/283/28371551002/ https://www.redalyc.org/journal/283/28371551002/html/ https://www.redalyc.org/journal/283/28371551002/28371551002.epub https://www.redalyc.org/journal/283/28371551002/movil |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Trends in long-term cancer survival in Cali, Colombia: 1998-2017 Luis Eduardo Bravo Luz Stella García Paola Collazos Jorge Holguín Isabelle Soerjomataram Adalberto Miranda-Filho Medicina Cali bias Cancer cancer Colombia Background: Population-based cancer survival is an indicator of the effectiveness of cancer services that reflects the survival of all cancer patients in the population, regardless of socioeconomic status and disease characteristics.Aim: Provision of an up-to-date survival estimate of patients recorded within Cali Population Cancer Registry (RPCC) in 1998-2017. As a second objective, results will be compared with those reported by the CONCORD study for cancers prioritized by the current Ten-Year Cancer Control Plan of Colombia, 2012-2021.Methods: Adult cancer cases (aged 15 to 99 years) for nine cancer types diagnosed between 1998 and 2017, with follow-up to 2018, were obtained from the RPCC. The 5-year age-standardized net survival estimates (NS) were estimated using the Pohar-Perme. The results for the period 1995- 2014 were compared with those reported by the CONCORD study for the following locations: stomach (C16), breast (C50), cervix (C53), prostate (C61), and lung (C33-34).Results: Five-year survival estimates for breast and prostate cancers improved ten percentage points through 2007 (70.8 to 81.1 for breast and 79.9 to 90.2 for prostate) and remained stable during 2008-2017. For cervical cancer, survival estimates has remained stable for the last two decades at 53%. For stomach cancer and lung cancer, five-year NS was lower than 25% over the study period. For colorectal cancer, survival estimates increased from 37.9% in 1998-2002 to 54.8% in 2013-2017. Compared to previous 5-year survival estimates of cases diagnosed in 2010-2014, the estimates in this study are significantly higher than those obtained by CONCORD. Survival estimates of patients diagnosed in 1995-2009 showed no difference to CONCORD study. Conclusions: Periodic update of vital status and date of last contact reduces bias in survival estimates in population-based cancer registries with passive follow-up. 2022 artículo científico 0120-8322 https://www.redalyc.org/articulo.oa?id=28371551002 https://www.redalyc.org/journal/283/28371551002/ https://www.redalyc.org/journal/283/28371551002/html/ https://www.redalyc.org/journal/283/28371551002/28371551002.epub https://www.redalyc.org/journal/283/28371551002/movil 10.25100/cm.v53i1.5082 en http://www.redalyc.org/revista.oa?id=283 Colombia Médica application/pdf Universidad del Valle Colombia Médica (Colombia) Num.1 Vol.53